Publication:
Response rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still's disease: Data from a large multicenter cohort

dc.contributor.authorALİBAZ ÖNER, FATMA
dc.contributor.authorDİRESKENELİ, RAFİ HANER
dc.contributor.authorsKalyoncu, Umut; Solmaz, Dilek; Emmungil, Hakan; Yazici, Ayten; Kasifoglu, Timucin; Kimyon, Gezmis; Balkarli, Ayse; Bes, Cemal; Ozmen, Mustafa; Alibaz-Oner, Fatma; Erten, Sukran; Cagatay, Yonca; Cetin, Gozde Yildirim; Yilmaz, Sedat; Yildiz, Fatih; Pamuk, Omer Nuri; Kucuksahin, Orhan; Kilic, Levent; Yazisiz, Veli; Karadag, Omer; Koca, Suleyman Serdar; Hayran, Mutlu; Akar, Servet; Aksu, Kenan; Akkoc, Nurullah; Keser, Gokhan; Gonullu, Emel; Kisacik, Bunyamin; Onat, Ahmet Mesut; Soy, Mehmet; Inanc, Nevsun; Direskeneli, Haner; Sayarlioglu, Mehmet; Erken, Eren; Turgay, Murat; Cefle, Ayse; Ertenli, Ihsan; Pay, Salih
dc.date.accessioned2022-03-12T20:30:28Z
dc.date.accessioned2026-01-10T17:54:35Z
dc.date.available2022-03-12T20:30:28Z
dc.date.issued2016
dc.description.abstractBackground: Adult-onset Still's disease (AOSD) is a rare condition, and treatment choices are frequently dependent on expert opinions. The objectives of the present study were to assess treatment modalities, disease course, and the factors influencing the outcome of patients with AOSD. Methods: A multicenter study was used to reach sufficient patient numbers. The diagnosis of AOSD was based on the Yamaguchi criteria. The data collected included patient age, gender, age at the time of diagnosis, delay time for the diagnosis, typical AOSD rash, arthralgia, arthritis, myalgia, sore throat, lymphadenopathy, hepatomegaly, splenomegaly, pleuritic, pericarditis, and other rare findings. The laboratory findings of the patients were also recorded. The drugs initiated after the establishment of a diagnosis and the induction of remission with the first treatment was recorded. Disease patterns and related factors were also investigated. A multivariate analysis was performed to assess the factors related to remission. Results: The initial data of 356 patients (210 females; 59%) from 19 centers were evaluated. The median age at onset was 32 (16-88) years, and the median follow-up time was 22 months (0-180). Fever (95.8%), arthralgia (94.9%), typical AOSD rash (66.9%), arthritis (64.6%), sore throat (63.5%), and myalgia (52.8%) were the most frequent clinical features. It was found that 254 of the 306 patients (83.0%) displayed remission with the initial treatment, including corticosteroids plus methotrexate with or without other disease-modifying antirheumatic drugs. The multivariate analysis revealed that the male sex, delayed diagnosis of more than 6 months, failure to achieve remission with initial treatment, and arthritis involving wrist/elbow joints were related to the chronic disease course. Conclusion: Induction of remission with initial treatment was achieved in the majority of AOSD patients. Failure to achieve remission with initial treatment as well as a delayed diagnosis implicated a chronic disease course in AOSD. (C) 2016 Elsevier Ltd. All rights reserved.
dc.identifier.doi10.1016/j.jaut.2016.02.010
dc.identifier.eissn1095-9157
dc.identifier.issn0896-8411
dc.identifier.pubmed26970681
dc.identifier.urihttps://hdl.handle.net/11424/234177
dc.identifier.wosWOS:000374919900006
dc.language.isoeng
dc.publisherACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
dc.relation.ispartofJOURNAL OF AUTOIMMUNITY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAdult-onset Still's disease
dc.subjectDisease modifying anti-rheumatic drugs
dc.subjectDisease pattern
dc.subjectRemission
dc.subjectMETHOTREXATE TREATMENT
dc.subjectEFFICACY
dc.titleResponse rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still's disease: Data from a large multicenter cohort
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage63
oaire.citation.startPage59
oaire.citation.titleJOURNAL OF AUTOIMMUNITY
oaire.citation.volume69

Files